Literature DB >> 32449000

A potential pitfall in the use of 99mTc-PYP imaging for diagnosing cardiac ATTR amyloidosis.

Christopher S G Murray1,2, Renee M Moadel2,3, James M Tauras1,2, Edgar Zamora2,3, Mark I Travin4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32449000     DOI： 10.1007/s12350-020-02199-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  1 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952
  1 in total
  2 in total

1.  A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.

Authors:  Mrinali Shetty
Journal:  J Nucl Cardiol       Date:  2021-03-02       Impact factor: 5.952

2.  Pitfalls of the Semi-Quantitative Analyzing 99mTc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution.

Authors:  Yuankai Zhu; Ruping Pan; Dan Peng; Qingjian Dong; Xiaohua Zhu
Journal:  Diagnostics (Basel)       Date:  2022-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.